ACRP blog

OCTOBER 4, 2023

For example, if two separate people complete the coverage analysis and budget, both need an understanding of the other document and process. If the budgeter does not know how to interpret a coverage analysis, they could easily budget incorrectly, which can lead to double billing and other major compliance concerns.

Research 59

Research Compliance Development 59

XTalks

APRIL 10, 2024

Legacy (Rank 14) Founded in 2018, Legacy is revolutionizing the reproductive health sector with its innovative approach to sperm analysis and storage solutions. Its innovative solutions, which include sacral neuromodulation devices, are transforming the lives of patients worldwide. million , increasing at a CAGR of 200.87

Life Science 52

Life Science Pharmacy Nurses Marketing 52

ACRP blog

OCTOBER 4, 2023

For example, if two separate people complete the coverage analysis and budget, both need an understanding of the other document and process. If the budgeter does not know how to interpret a coverage analysis, they could easily budget incorrectly, which can lead to double billing and other major compliance concerns.

Research 52

Research Compliance Development 52

Drug Discovery World

OCTOBER 26, 2023

However, in-depth analysis of proteomics data can be challenging; it requires powerful computational tools and strong scientific expertise. One of the key advantages of ScreenPep is being able to benefit from high throughput without compromising coverage and accuracy. phosphorylations or ubiquitinations).

Drugs 52

Drugs Protein Genome Genomics 52

WCG Clinical

MARCH 30, 2023

WCG’s InvestigatorSpace® offers customizable training solutions to bring accurate and detailed training to life while reducing the time spent on developing assets by an average of 60%. Request a demo or learn about more InvestigatorSpace training solutions for clinical research at wcgclinical.com/InvestigatorSpace.

Dermatology 52

Dermatology Clinical Trials Clinical Trials Trials 52

Pharmaceutical Technology

DECEMBER 27, 2022

Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. In a data-backed analysis, she further explored how the most number of designations are awarded to cancer drugs , and genetic disorders have the largest share of orphan therapies.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccination 306

WCG Clinical

MAY 1, 2023

How does WCG’s new eEDSS solution overcome some of these challenges? Whenever we can cause the scoring to be done exactly the same way each visit by each evaluator, we can reduce variability in outcome assessments. A: There are many advantages to the electronic capture of outcome assessments. International Journal of MS Care.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Dermatology 52

pharmaphorum

DECEMBER 21, 2021

Analysis frameworks provided by augmented analytics can help companies protect market share gains by adjusting for gaps in coverage. In use cases like the one above, companies can help grow market share by overlaying HCPs against sales coverage, which can be used to target underperforming HCPs. and consulting roles.

Life Science 115

Life Science Sales Scientist Vaccination 115

Pharma Marketing Network

SEPTEMBER 6, 2023

This can help to reduce the burden of travel on clinicians and increase access to care for patients”, “[to write] letters of necessity for coverage, medication needs and side effects for patients.” eHealthcare Solutions Founder and CEO, R.J. Read the complete POV AI Trends on Current and Future Healthcare (Parts One and Two) here.

Research 64

Research Marketing Pharma Companies Branding 64

WCG Clinical

AUGUST 22, 2023

PRINCETON, NJ, August 22, 2023: WCG, the global leader in providing solutions that measurably improve the quality, efficiency, and safety of clinical research, today announces the WCG MAGI Clinical Research Conference, an educational mainstay for clinical trial professionals for more than 15 years, is going virtual for its fall 2023 event.

Clinical Research 52

Clinical Research Research Compliance Clinical Trials 52

Pharma Marketing Network

SEPTEMBER 6, 2023

This can help to reduce the burden of travel on clinicians and increase access to care for patients”, “[to write] letters of necessity for coverage, medication needs and side effects for patients.” eHealthcare Solutions Founder and CEO, R.J. Read the complete POV AI Trends on Current and Future Healthcare (Parts One and Two) here.

Research 52

Research Marketing Pharma Companies Branding 52

The Pharma Data

MARCH 27, 2022

In the pooled 52-week analysis, patients at baseline had a mean Severity of Alopecia Tool (SALT) score of 85.5 scalp hair coverage); severe AA is defined as having a SALT score ?50 20, or 80% or more scalp hair coverage, and nearly three out of four of those patients (74.1%, n=149/201) also achieved a SALT score ?10,

Dermatology 40

Dermatology Medicine Licensing Licensing 40

Drug Discovery World

FEBRUARY 6, 2023

Figure 1: Scalable and reproducible research approach for systems biology data management and analysis. All analytical steps starting from the raw data including data processing, analysis, and reporting are automated facilitating start-to-end reproducibility. It also helps to quickly address unplanned changes.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

WCG Clinical

MAY 15, 2023

Additionally, on the back end, the database didn’t allow for proper analysis to satisfy regulators. Solution The Epilepsy Study Consortium collaborated with industry leaders, including WCG, study coordinators, data managers, sponsors, and participants to create a better electronic seizure diary.

Clinical Research 52

Clinical Research Development Trials Research 52

pharmaphorum

JUNE 4, 2021

A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how these products can find a smoother path to market. This article appears in our free digital magazine Deep Dive: Market Access 2021.

Marketing 45

Marketing Life Science Production Regulation 45

Drug Discovery World

JULY 19, 2023

The primary analysis population for which the study was powered was comprised of people with an intermediate level of tau and clinical symptoms of Alzheimer’s disease. The high tau participants were combined with the intermediate tau population in an additional primary analysis of all participants enrolled.

Trials 52

Trials Clinical Trials Clinical Trials Research 52

Drug Discovery World

DECEMBER 29, 2023

Moreover, this technique requires specialised expertise in order to acquire reliable data and perform subsequent analysis. On the other hand, SEC offers a more accessible option for sample analysis, but typically delivers lower resolution compared to other advanced techniques. How can we streamline this process?

Protein 52

Protein In-Vitro Research Drugs 52

pharmaphorum

OCTOBER 26, 2020

A new analysis looks at these barriers and asks how they could be overcome. In addition to representing more efficient and cost-effective options in healthcare coverage, these measures offer the prospect of positive health outcomes and quality of life for patients. Understanding payer views of preventive care.

Life Science 129

Life Science Genetics Development Vaccination 129

XTalks

AUGUST 18, 2023

Iveric Bio, a company of Astellas, has secured recent approval from the US Food and Drug Administration (FDA) for its innovative drug, Izervay (avacincaptad pegol intravitreal solution). mL of a 20 mg/mL solution), administered via intravitreal injection into each affected eye monthly for up to 12 months.

FDA Approval 52

FDA Approval Drugs Clinical Trials Clinical Trials 52

Cloudbyz

MARCH 12, 2021

Digitalization and real-time overview: Sponsor or CRO can implement a technology-based solution to manage the entire setup process, ensuring no data is lost, thus minimizing the risk without impacting the clinical study. For example, you may consider outsourcing coverage analysis as it is a complicated procedure and need a lot of training.

Clinical Trials 88

Clinical Trials Clinical Trials Trials Research 88

pharmaphorum

APRIL 27, 2022

I don’t know’ ” As the pandemic progressed, it quickly became clear that identifying and measuring omnichannel marketing success would require companies to think outside of the box and develop solutions that effectively addressed the unique needs of modern marketing. You’ve no idea where you’re in the race.

Marketing 115

Marketing Sales Production Development 115

Cloudbyz

MARCH 12, 2021

Sponsors or CROs can implement a technology-based solution to manage the entire setup process , ensuring no data is lost, thus minimizing the risk without impacting the clinical study. Apart from technological interventions in the study startup, focus on communicating with the CROs and sponsors closely with integrated CTMS solutions.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

Intouch Solutions

MARCH 2, 2022

That introduces significant challenges, but there are time-tested solutions to engage relevantly with unique customer segments to optimize the sales and marketing mix. Poor insurance coverage can create a situation where demand generation from HCPs and patients faces a “brick wall” effect.

Marketing 52

Marketing Branding Sales Pharmacy 52

XTalks

JULY 29, 2021

However, increasing diversity in Alzheimer’s trials is a multifactorial issue that requires understanding and solutions that address the many factors at play. This analysis was based on the identification of over 2,700 individual exclusion criteria that the research team organized into 56 categories.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Research 98

WCG Clinical

JULY 17, 2023

Listen in as we discuss the results of WCG’s recently published 2023 Clinical Research Site Challenges Survey Report , gain insights from our guests on solutions their organizations have implemented to reduce site burden, and share perspectives on how sites, sponsors, and CROs can work to improve site and trial efficiency.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52

pharmaphorum

DECEMBER 19, 2022

Taking a brief look back to pharmaphorum’s coverage of Day One of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium, in November – where the foci were “innovation, equity, and excellence”. Rizvi replied that there aren’t large-scale studies or a crisis analysis plan in Europe for oncology.

Genome 97

Genome Genomics Development Doctors 97

Drug Discovery World

JUNE 6, 2023

So, I really look forward to the coming year and being in beautiful San Diego next year.” Meet the biotech Sygnature Discovery is an integrated drug discovery and non-clinical solutions provider, offering expertise across a range of therapeutic areas and biological target classes. It’s really all driven by the Archer technology.

Protein 52

Protein DNA RNA Research 52

Drug Discovery World

AUGUST 12, 2022

Analysis of 87 suppliers’ catalogues identified 2522 unique salt/solvate descriptors (see Section 7: Success metrics), which illustrates the amount of variability. millimolar solution of the proton-pump inhibitor pantoprazole sodiumsesquihydrate for an assay. unadorned ‘parent’ molecule)but as a salt or solvated form (e.g.

Drugs 52

Drugs Bioassay Development Research 52

XTalks

OCTOBER 12, 2022

We [Philips Pharma Solutions, formerly BioTel Research] have successfully ran multi-site DCE-MRI trials,” said Edward Ashton, PhD, VP, Oncology Imaging, Philips Pharma Solutions. Figure courtesy of Philips Pharma Solutions, formerly BioTel Research. Figure courtesy of Philips Pharma Solutions, formerly BioTel Research.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

Drug Discovery World

OCTOBER 14, 2022

Figure 2: Quantitative MALDI-TIMS-MS analysis of glucose in the presence of the isomer fructose, demonstrating quantitation of isomers that would be indistinguishable by mass spectrometry alone. Maintaining the rapid analysis times needed for HTS .

Drugs 52

Drugs In-Vitro Development Production 52

The Pharma Data

DECEMBER 28, 2020

Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. TEMPLE CITY, Calif.,

Genetics 52

Genetics Sales Gene Sequencing Marketing 52

The Pharma Data

JANUARY 6, 2021

Alternatively, copies may be obtained, when available, from Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attn: Prospectus Department, by email at PostSaleManualRequests@broadridge.com or by telephone at (833) 297-2926, or from William Blair & Company, L.L.C.,

Dermatology 40

Dermatology Genome Genomics Production 40

XTalks

MAY 20, 2021

John Reites, CEO, THREAD , a company that offers a comprehensive DCT platform, told Xtalks that due to widespread coverage of COVID-19 vaccine clinical trials, more people know about clinical trials and their benefits now. “We A major area of consideration and concern has been ensuring quality data capture.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Vaccination 105

XTalks

FEBRUARY 4, 2021

DNA analysis has become an almost imperative first step in clinical sample analysis. Dr. Bernard says all of the information from DNA analysis has to be re-loaded into a biobank databank so that it’s reusable by other people. What’s the solution?”. The solution is to get the right information out.

Research 98

Research Biobanking Drugs Genome 98

Cloudbyz

JUNE 1, 2023

It’s a powerful tool for both administrators and developers to create tailored solutions for their unique business processes. Export and Print: You can export reports and dashboards to Excel or other formats for further analysis, or you can print them. Permissions can be set to control who can see which data.

Compliance 87

Compliance Development Branding Production 87

The Pharma Data

FEBRUARY 8, 2021

to €305 million driven by increased vaccination coverage and the launch of the differentiated portfolio (Efluelda ® , a quadrivalent Influenza Vaccine-High Dose and Supemtek ® , a recombinant influenza vaccine). Influenza vaccines sales increased by 24.6% In Europe, sales grew 118.3% In the U.S. sales increased 10.2%

Sales 52

Sales Vaccination Vaccine Production 52

The Pharma Data

FEBRUARY 4, 2021

to €305 million driven by increased vaccination coverage and the launch of the differentiated portfolio (Efluelda ® , a quadrivalent Influenza Vaccine-High Dose and Supemtek ® , a recombinant influenza vaccine). Influenza vaccines sales increased by 24.6% In Europe, sales grew 118.3% In the U.S. sales increased 10.2%

Sales 52

Sales Vaccination Vaccine Production 52